1. |
Rahib L, Smith B D, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 2014, 74(11): 2913-2921.
|
2. |
Zavoral M, Minarikova P, Zavada F, et al. Molecular biology of pancreatic cancer. World J Gastroenterol, 2011, 17(24): 2897-2908.
|
3. |
Yeo D, He H, Baldwin G S, et al. The role of p21-activated kinases in pancreatic cancer. Pancreas, 2015, 44(3): 363-369.
|
4. |
Jagadeeshan S, Krishnamoorthy Y R, Singhal M, et al. Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis. Oncogene, 2014, 34(4): 455-464.
|
5. |
Ye D Z, Field J. PAK signaling in cancer. Cell Logist, 2012, 2(2): 105-116.
|
6. |
Kumar R, Gururaj A E, Barnes C J. p21-activated kinases in cancer. Nat Rev Cancer, 2006, 6(6): 459-471.
|
7. |
Radu M, Semenova G, Kosoff R, et al. PAK signaling during the development and progression of cancer. Nat Rev Cancer, 2014, 14(1): 13-25.
|
8. |
Rudolph J, Crawford J J, Hoeflich K P, et al. Inhibitors of p21-activated kinases (PAKs). J Med Chem, 2015, 58(1): 111-129.
|
9. |
Wang J, Zhu Y, Chen J, et al. Identification of a novel PAK1 inhibitor to treat pancreatic cancer. Acta Pharmaceutica Sinica B, 2020, 10(4): 603-614.
|
10. |
Chauhan S C, Ebeling M C, Maher D M, et al. MUC13 mucin augments pancreatic tumorigenesis. Mol Cancer Ther, 2012, 11(1): 24-33.
|
11. |
Kimmelman A C, Hezel A F, Aguirre A J, et al. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A, 2008, 105(49): 19372-19377.
|
12. |
Yeo D, Phillips P, Baldwin G S, et al. Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer. Int J Cancer, 2017, 140(9): 2101-2111.
|
13. |
Yeo D, Hong H, Patel O, et al. FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine. BMC Cancer, 2016, 16: 24.
|
14. |
Yang Y, Sun M, Yao W, et al. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib. J Immunother Cancer, 2020, 8(1): e000317.
|
15. |
唐晓丽, 刘真君, 周鹏, 等. 复方苦参注射液联合GEMOX方案治疗中晚期胰腺癌临床疗效及对肿瘤标志物指标的影响. 湖北中医药大学学报, 2021, 23(2): 56-59.
|
16. |
丛日楠, 乔建文. 复方苦参注射液联合放疗治疗晚期胰腺癌的近期疗效、安全性及对患者生活质量的影响. 现代中西医结合杂志, 2019, 28(12): 1335-1338.
|
17. |
Zhou W, Huang Z, Wu C, et al. Investigation on the clinical efficacy and mechanism of compound kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment. J Ethnopharmacol, 2021, 279: 114386.
|
18. |
Ur Rashid H, Rasool S, Ali Y, et al. Anti-cancer potential of sophoridine and its derivatives: recent progress and future perspectives. Bioorg Chem, 2020, 99: 103863.
|
19. |
Cho Y R, Lee J H, Kim J H, et al. Matrine suppresses KRAS-driven pancreatic cancer growth by inhibiting autophagy-mediated energy metabolism. Mol Oncol, 2018, 12(7): 1203-1215.
|
20. |
朱锦辉, 陈燕, 叶清煌, 等. 苦参碱对胰腺癌吉西他滨耐药及Aurora-A表达的影响. 浙江临床医学, 2016, 18(7): 1191-1193.
|
21. |
Chen J, Yang J, Wei Q, et al. Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells. Cell Commun Signal, 2020, 18(1): 55.
|
22. |
王鹏飞, 王京辉, 段秀梅, 等. HPLC法同时测定复方苦参注射液中7个成分含量及指纹图谱研究. 药物分析杂志, 2022, 42(7): 1101-1109.
|
23. |
Karpov A S, Amiri P, Bellamacina C, et al. Optimization of a dibenzodiazepine hit to a potent and selective allosteric PAK1 inhibitor. ACS Med Chem Lett, 2015, 6(7): 776-781.
|
24. |
Molli P R, Li D Q, Murray B W, et al. PAK signaling in oncogenesis. Oncogene, 2009, 28(28): 2545-2555.
|
25. |
Liu T, Song Y, Chen H, et al. Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull, 2010, 33(10): 1740-1745.
|
26. |
Ma Y, Zou F, Xiong J, et al. Effect of matrine on HPAC cell migration by down-regulating the expression of MT1-MMP via Wnt signaling. Cancer Cell Int, 2015, 15: 59.
|
27. |
任丽平, 李先佳, 金少举. 槐定碱对人胰腺癌细胞株capan-1增殖及侵袭能力的影响. 河南科技大学学报: 医学版, 2016, 34(4): 244-246.
|